Varian Medical Systems Sees "Healthy Growth" in Revenue and Orders in Q2

Thanh Le | | Radiology Business | Business Intelligence
Varian Medical Systems is reporting "healthy" growth in revenue and net orders for the second quarter of fiscal year 2012. The company generated $720 million in revenues during the quarter, up 11 percent from the prior-year period, and ended the period with a $2.7 billion backlog, up 18 percent from the same point in fiscal year 2011. Net earnings of $0.94 per diluted share are up 9 percent from $0.86 per diluted share in the same quarter last year. The results include a $2.5 million or $0.02 per diluted share restructuring charge associated with realigning resources to address growth prospects in emerging markets. The company ended the second quarter with $617 million in cash and cash equivalents and $162 million of debt. For fiscal 2012, the company expects earnings to increase over fiscal 2011 totals by 9 to 12 percent to a range of $3.76 to $3.84 per diluted share, and that annual revenues should increase over the fiscal 2011 total by about 10 percent.In a separate announcement, the Palo Alto, Calif-based company says it has inked a deal with Siemens to jointly market and represent each other's imaging and radiotherapy products, as well as develop software interfaces to allow their imaging products to work together. For the full report, click here.

Thanh Le

Related Content

Orano Med breaks ground on $265M thorium production site
Image-interpretation market scoreboard: Radiologists 72%, others 28%
Lantheus lands rights to budding radiopharmaceuticals for initial outlay of $35M
17 short-term strategies to address the national radiologist shortage
‘SR’ onboards another independent practice, its 1st in the Natural State
Analysis: Allied radiology professionals generate millions of dollars per year in indirect revenues alone

Around the web

Health Imaging
Nearly $800,000 settlement offered to family of man who died during MRI exam

The patient, who was being cared for in the ICU, was not accompanied or monitored by nursing staff during his exam, despite being sedated.

Cardiovascular Business
Global shortage of nuclear imaging isotopes may be over

The nuclear imaging isotope shortage of molybdenum-99 may be over now that the sidelined reactor is restarting. ASNC's president says PET and new SPECT technologies helped cardiac imaging labs better weather the storm.

Cardiovascular Business
‘A huge win’: CMS significantly increases Medicare payments for cardiac CT

CMS has more than doubled the CCTA payment rate from $175 to $357.13. The move, expected to have a significant impact on the utilization of cardiac CT, received immediate praise from imaging specialists.